Hongyan Li

机构：National Blood Transfusion Service · ORCID：0000-0003-0014-3450

发表论文 50 篇 · 总被引 814 次 · h-index 15

代表论文

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus (2020 · Stem Cells International · 被引 72)
Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis (2020 · Stem Cell Research & Therapy · 被引 40)
MicroRNA‑206 suppresses proliferation and predicts poor prognosis of HR‑HPV-positive cervical cancer cells by targeting G6PD (2018 · Oncology Letters · 被引 37)
Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis (2021 · Stem Cell Research & Therapy · 被引 36)
The role of hypoxia-inducible factor stabilizers in the treatment of anemia in patients with chronic kidney disease (2018 · Drug Design Development and Therapy · 被引 35)
<p>Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis</p> (2019 · Drug Design Development and Therapy · 被引 20)